| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0047 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |